-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Randomized Controlled Trials as Topic are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Randomized Controlled Trials as Topic.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- The ethics of placebo in studies with fracture end points in osteoporosis.
Stein CM, Ray WA
(2010) N Engl J Med 363: 1367-70; discussion e21 - New drugs for rheumatoid arthritis.
Roberts LJ
(2004) N Engl J Med 351: 2659-61; author reply 2659-61 - Hemodialysis.
Himmelfarb J, Ikizler TA
(2010) N Engl J Med 363: 1833-45 - Observational studies of drugs and mortality.
Ray WA
(2005) N Engl J Med 353: 2319-21 - Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group
(2011) Lancet 378: 412-9 - Placebo-controlled studies in rheumatoid arthritis: ethical issues.
Stein CM, Pincus T
(1999) Lancet 353: 400-3 - Helicobacter pylori and gastrointestinal tract adenocarcinomas.
Peek RM, Blaser MJ
(2002) Nat Rev Cancer 2: 28-37 - Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Mills JL, DerSimonian R, Raymond E, Morrow JD, Roberts LJ, Clemens JD, Hauth JC, Catalano P, Sibai B, Curet LB, Levine RJ
(1999) JAMA 282: 356-62 - American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.
Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, Milton DT, Strawn JR, Wakelee HA, Giaccone G
(2011) J Clin Oncol 29: 2121-7 - Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib.
Richards CJ, Je Y, Schutz FA, Heng DY, Dallabrida SM, Moslehi JJ, Choueiri TK
(2011) J Clin Oncol 29: 3450-6 - 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
Azzoli CG, Temin S, Aliff T, Baker S, Brahmer J, Johnson DH, Laskin JL, Masters G, Milton D, Nordquist L, Pao W, Pfister DG, Piantadosi S, Schiller JH, Smith R, Smith TJ, Strawn JR, Trent D, Giaccone G, American Society of Clinical Oncology
(2011) J Clin Oncol 29: 3825-31 - Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
Hubers SA, Brown NJ
(2016) Circulation 133: 1115-24 - Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics.
Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, Feldman DR, Pagliaro LC, Miller RC, Vaughn DJ, Einhorn LH, Cox NJ, Dolan ME, Platinum Study Group
(2014) J Natl Cancer Inst 106: - Gastrointestinal carcinoma antigen GA733: target for immunodestruction and potential modifier of invasiveness and chemoresponsiveness.
Zutter MM
(1998) J Natl Cancer Inst 90: 642-4 - Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data.
Hadley J, Yabroff KR, Barrett MJ, Penson DF, Saigal CS, Potosky AL
(2010) J Natl Cancer Inst 102: 1780-93 - The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents.
Kreimer AR, Sherman ME, Sahasrabuddhe VV, Safaeian M
(2015) J Natl Cancer Inst 107: - Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials.
Holtkamp FA, de Zeeuw D, de Graeff PA, Laverman GD, Berl T, Remuzzi G, Packham D, Lewis JB, Parving HH, Lambers Heerspink HJ
(2011) Eur Heart J 32: 1493-9 - Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors.
Li W, Croce K, Steensma DP, McDermott DF, Ben-Yehuda O, Moslehi J
(2015) J Am Coll Cardiol 66: 1160-78 - Clinical judgment and therapeutic decision making.
Hlatky MA, Califf RM, Harrell FE, Lee KL, Mark DB, Muhlbaier LH, Pryor DB
(1990) J Am Coll Cardiol 15: 1-14 - Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis.
Honan MB, Harrell FE, Reimer KA, Califf RM, Mark DB, Pryor DB, Hlatky MA
(1990) J Am Coll Cardiol 16: 359-67 - A three-part intervention to change the use of hormone replacement therapy in response to new evidence.
Roumie CL, Grogan EL, Falbe W, Awad J, Speroff T, Dittus RS, Elasy TA
(2004) Ann Intern Med 141: 118-25 - Aspirin use and potential mechanisms for colorectal cancer prevention.
Williams CS, Smalley W, DuBois RN
(1997) J Clin Invest 100: 1325-9 - Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.
Roden DM, Van Driest SL, Wells QS, Mosley JD, Denny JC, Peterson JF
(2018) Circ Res 122: 1176-1190 - Sepsis trials. Intersection of investigation, regulation, funding, and practice.
Bernard GR
(1995) Am J Respir Crit Care Med 152: 4-10 - Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.
Haas DW, Bartlett JA, Andersen JW, Sanne I, Wilkinson GR, Hinkle J, Rousseau F, Ingram CD, Shaw A, Lederman MM, Kim RB, Adult AIDS Clinical Trials Group
(2006) Clin Infect Dis 43: 783-6 - Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001).
Furst DE, Keystone EC, Breedveld FC, Kalden JR, Smolen JS, Antoni CE, Burmester GR, Crofford LJ, Kavanaugh A
(2001) Ann Rheum Dis 60 Suppl 3: iii2-5 - Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures.
Assassi S, Wang X, Chen G, Goldmuntz E, Keyes-Elstein L, Ying J, Wallace PK, Turner J, Zheng WJ, Pascual V, Varga J, Hinchcliff ME, Bellocchi C, McSweeney P, Furst DE, Nash RA, Crofford LJ, Welch B, Pinckney A, Mayes MD, Sullivan KM
(2019) Ann Rheum Dis 78: 1371-1378 - A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.
Cooper GM, Johnson JA, Langaee TY, Feng H, Stanaway IB, Schwarz UI, Ritchie MD, Stein CM, Roden DM, Smith JD, Veenstra DL, Rettie AE, Rieder MJ
(2008) Blood 112: 1022-7 - Muscle wasting in kidney disease: Let's get physical.
Ikizler TA, Himmelfarb J
(2006) J Am Soc Nephrol 17: 2097-8 - Considerations and challenges in defining optimal iron utilization in hemodialysis.
Charytan DM, Pai AB, Chan CT, Coyne DW, Hung AM, Kovesdy CP, Fishbane S, Dialysis Advisory Group of the American Society of Nephrology
(2015) J Am Soc Nephrol 26: 1238-47 - Obesity and oxidative stress predict AKI after cardiac surgery.
Billings FT, Pretorius M, Schildcrout JS, Mercaldo ND, Byrne JG, Ikizler TA, Brown NJ
(2012) J Am Soc Nephrol 23: 1221-8 - Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence.
Egan JB, Thompson PA, Ashbeck EL, Conti DV, Duggan D, Hibler E, Jurutka PW, Leroy EC, MartÃnez ME, Mount D, Jacobs ET
(2010) Cancer Res 70: 1496-504 - Dialysis frequency versus dialysis time, that is the question.
Hakim RM, Saha S
(2014) Kidney Int 85: 1024-9 - Aflibercept.
Ciombor KK, Berlin J, Chan E
(2013) Clin Cancer Res 19: 1920-5 - A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303.
Innocenti F, Owzar K, Cox NL, Evans P, Kubo M, Zembutsu H, Jiang C, Hollis D, Mushiroda T, Li L, Friedman P, Wang L, Glubb D, Hurwitz H, Giacomini KM, McLeod HL, Goldberg RM, Schilsky RL, Kindler HL, Nakamura Y, Ratain MJ
(2012) Clin Cancer Res 18: 577-84 - Addressing literacy and numeracy to improve diabetes care: two randomized controlled trials.
Cavanaugh K, Wallston KA, Gebretsadik T, Shintani A, Huizinga MM, Davis D, Gregory RP, Malone R, Pignone M, DeWalt D, Elasy TA, Rothman RL
(2009) Diabetes Care 32: 2149-55 - Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.
Triolo TM, Chase HP, Barker JM, DPT-1 Study Group
(2009) Diabetes Care 32: 769-73 - ACR 20: clinical or statistical significance?
Pincus T, Stein CM
(1999) Arthritis Rheum 42: 1572-6 - Clinical studies of drug effects in humans.
Ray WA
(1996) Clin Chem 42: 1306-11 - Course of Disinhibited Social Engagement Disorder From Early Childhood to Early Adolescence.
Guyon-Harris KL, Humphreys KL, Fox NA, Nelson CA, Zeanah CH
(2018) J Am Acad Child Adolesc Psychiatry 57: 329-335.e2
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
